All
Malaria drug hydroxychloroquine may treat COVID-19
March 20th 2020As the number of patients infected with COVID-19 continues to rise, several experts are relaying data they say may save lives and change the course of this pandemic. According to Drs. George Martin, Ted Rosen, Sheila Fallon-Friedlander, Albert Yan, and James Treat, recent data provides evidence of the use of HCQ, its dosing, as well as epidemiology insights that will serve all healthcare practitioners in the fight against the novel coronavirus, COVID-19.
FDA grants priority review for dupilumab in pediatric AD
January 31st 2020The FDA announced it has accepted a priority review of dupilumab for the treatment of moderate-to-severe AD in pediatric patients 6 to 11 years of age. The drug is already approved for treatment of AD in adolescents and adults.
Susan Weinkle, M.D., presented JDD outstanding educator award
January 21st 2020South Florida practitioner Dr. Susan Weinkle received the JDD Outstanding Educator & Mentor in Dermatology at the ODAC held Jan.17-20 in Orlando, Fla. The award recognizes continuing contributions to the dermatology industry through education.
Psoriasis cream safe, effective suggests EU phase 3 results
December 23rd 2019Results from an EU phase 3 clinical trial of a combination of betamethasone dipropionate and calcipotriene cream showed improved patient convenience, quality of life and efficacy compared to a betamethasone dipropionate and calcipotriene gel for patients with plaque psoriasis.
Fungal diagnostic preparations may prevent misdiagnoses
December 10th 2019Performing fungal diagnostic preparations to confirm a suspected fungal infection should be a central tenant in dermatology, says this expert. But more than one-fifth of dermatologists surveyed said they never or rarely do fungal preparations in practice.